Staphylococcus aureus immune globulin - Biotest

Drug Profile

Staphylococcus aureus immune globulin - Biotest

Alternative Names: S. aureus immune globulin - Biotest; Staphylococcus aureus Immune Globulin Intravenous (human) - Biotest; Altastaph

Latest Information Update: 10 Aug 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nabi Biopharmaceuticals
  • Developer Biotest Pharmaceuticals
  • Class Antibacterials; Immunoglobulins; Polyclonal antibodies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Staphylococcal infections
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Staphylococcal infections

Most Recent Events

  • 01 Aug 2018 Biotest Pharmaceuticals has been acquired by Grifols Shared Services North America
  • 31 May 2012 Discontinued - Phase-II for Staphylococcal infections in USA (IV)
  • 04 Dec 2007 Biotest Pharma acquires Nabi Biopharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top